Endocrine Testing Market to Be Worth US$2.03 Billion by 2019: Transparency Market Research

ALBANY, N.Y.--()--Transparency Market Research has announced the release of a report titled “Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.” This report states that the global endocrine testing market that was valued at US$1.53 billion in the year 2012 is expected to reach US$2.03 billion by 2019 growing at a CAGR of 4.3%.

Browse Report: http://www.transparencymarketresearch.com/endocrine-testing-market.html

The global endocrine testing market has been segmented on the basis of the type of tests, the end-users, the diagnostic platforms, and geography. Based on type of tests, this market is classified into eleven main hormone tests. Clinical chemistry, immunoassay, and tandem mass spectrometry are some of the main technologies used in endocrine testing market. Commercial laboratories, hospitals, healthcare centers, and home based test offices are the end-users operating in this market.

Request Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645

Regionally, the global endocrine testing market is divided into North America, Europe, the Asia Pacific, and Rest of the World. This market is led by Europe because of the availability of skilled healthcare professionals, and a technologically modified infrastructure. The Asia Pacific is expected to report robust growth in the forthcoming years due to greater government focus on the healthcare sector, and better utilization of the unexploited potential. The global endocrine testing market is driven by rising demand for technologically enhanced medical solutions, and increasing disposable incomes. Uncertain reimbursement policies and high costs of developing the technologies are the challenges facing this market. This report includes detailed company profiles of the prominent players in the global endocrine testing market. The key market participants are Thermo Fisher Scientific, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., Agilent Technologies, bioMerieux, Quest Diagnostics, and Siemens Healthcare.

Press Release: http://www.transparencymarketresearch.com/pressrelease/endocrine-testing-market.htm

Other Reports:

Biological Drugs Market: http://www.transparencymarketresearch.com/biological-drugs-market.html

Hospital Infection Therapeutics Market: http://www.transparencymarketresearch.com/hospital-infection-therapeutics.html

About Us

TMR is a U.S. based market intelligence company driven by high-pedigree consultants and researchers. TMR leverages its Syndicated Research, Custom Research, and Market Consulting expertise to help businesses make accurate decisions. TMR’s exclusive blend of quantitative forecasting and trends analysis draws on proprietary data sources and techniques, while their data repository is continuously updated to reflect the latest trends.

Contacts

Transparency Market Research
Ms. Sheela AK, +1-518-618-1030
USA-Canada Toll Free: 866-552-3453
sales@transparencymarketresearch.com
http://www.transparencymarketresearch.com/

Release Summary

Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

Contacts

Transparency Market Research
Ms. Sheela AK, +1-518-618-1030
USA-Canada Toll Free: 866-552-3453
sales@transparencymarketresearch.com
http://www.transparencymarketresearch.com/